Fortfahren mit
L3045
β-Lactamase from Pseudomonas fluorescens
lyophilized powder, recombinant, expressed in E. coli
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 5 units | Warenkorb auf Verfügbarkeit prüfen | € 493,00 |
Über diesen Artikel
Recombinant:
expressed in E. coli
€ 493,00
Warenkorb auf Verfügbarkeit prüfen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenrecombinant
expressed in E. coli
Quality Level
form
lyophilized powder
enzyme activity
7.5-15 units/mg solid
shipped in
wet ice
storage temp.
2-8°C
Physical form
Lyophilized powder containing potassium phosphate and sodium bicarbonate
Other Notes
One unit will hydrolyze 1.0 μmole of benzylpenicillin per minute at pH 7.0 at 25 °C
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant - |
| form lyophilized powder | form ammonium sulfate suspension | form lyophilized powder | form powder |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| shipped in wet ice | shipped in wet ice | shipped in - | shipped in - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 100 |
| enzyme activity 7.5-15 units/mg solid | enzyme activity - | enzyme activity - | enzyme activity - |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Indian public health leaders move to reduce antimicrobial resistance.
Mike Mitka
JAMA, 309(6), 531-532 (2013-02-14)
A A Alsultan et al.
Journal of medical microbiology, 62(Pt 6), 885-888 (2013-03-23)
Carbapenem-resistant Acinetobacter baumannii is becoming increasingly prevalent in patients with diabetes mellitus in the Middle East. We examined the relationship of these bacteria and their resistance mechanisms to the diabetic disease status of patients in Saudi Arabia. Susceptibilities of 271
Mayuri Trivedi et al.
The Journal of the Association of Physicians of India, 60, 28-30 (2013-02-15)
In India where the prevalence of extended spectrum beta lactamase (ESBL) producing organisms among gram negative organisms is 60-70% and Ertapenem was unavailable at the beginning of this study, exclusive use of Group 2 Carbapenems (Imipenem and Meropenem) for treatment
Global Trade Item Number
| SKU | GTIN |
|---|---|
| L3045-5UN | 04061833950807 |